Dáil Éireann Debate, Wednesday - 13 January 2021
378. Deputy Cian O'Callaghan asked the Minister for Foreign Affairs his views on the waiving of intellectual property rules for Covid-19 vaccines and other related drugs in order to assist poorer countries in responding to the pandemic; and if he will make a statement on the matter. [45149/20]
View answerThe Covid-19 pandemic and the global search for a vaccine has demonstrated the importance of pooling resources, scientific information and knowledge in order to protect people, including in poorer countries. Any endeavour to enhance resources available, and share relevant knowledge, should be welcomed and supported.
During this public health crisis, a well-functioning ecosystem for the protection and enforcement of intellectual property rights is an important incentive for the research and development of novel vaccines, medicines and treatments. Ireland will continue to engage with partners to find innovative ways to support these aims, part of our comprehensive global response to the global challenge. For 2021, Irish Aid is planning at least €50 million in support of Global Health, working with relevant multilateral agencies including the WHO, sustaining health systems (including maintaining capacity for vaccine campaigns), ensuring attention to other diseases, and funding the work of the Health Service Executive (HSE) Global Health Programme in Ethiopia, Mozambique and elsewhere. This includes an additional allocation of €5 million in support of COVAX (the global Covid-19 vaccine facility), which will ensure developing countries have access to vaccines, as well as supporting the WHO role in ensuring equity and fairness in the process.
